- Home
- OMI vs ORIC Comparison
OMI vs ORIC Comparison
Compare OMI & ORIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OMI
- ORIC
- Stock Information
- Founded
- OMI 1882
- ORIC 2014
- Country
- OMI United States
- ORIC United States
- Employees
- OMI N/A
- ORIC N/A
- Industry
- OMI Medical Specialities
- ORIC Biotechnology: Pharmaceutical Preparations
- Sector
- OMI Health Care
- ORIC Health Care
- Exchange
- OMI Nasdaq
- ORIC Nasdaq
- Market Cap
- OMI 909.7M
- ORIC 750.6M
- IPO Year
- OMI N/A
- ORIC 2020
- Fundamental
- Price
- OMI $12.25
- ORIC $8.50
- Analyst Decision
- OMI Buy
- ORIC Strong Buy
- Analyst Count
- OMI 6
- ORIC 9
- Target Price
- OMI $19.58
- ORIC $18.75
- AVG Volume (30 Days)
- OMI 902.0K
- ORIC 499.8K
- Earning Date
- OMI 11-04-2024
- ORIC 11-12-2024
- Dividend Yield
- OMI N/A
- ORIC N/A
- EPS Growth
- OMI N/A
- ORIC N/A
- EPS
- OMI N/A
- ORIC N/A
- Revenue
- OMI $10,660,960,000.00
- ORIC N/A
- Revenue This Year
- OMI $4.87
- ORIC N/A
- Revenue Next Year
- OMI $4.01
- ORIC N/A
- P/E Ratio
- OMI N/A
- ORIC N/A
- Revenue Growth
- OMI 4.22
- ORIC N/A
- 52 Week Low
- OMI $11.42
- ORIC $6.33
- 52 Week High
- OMI $28.35
- ORIC $16.65
- Technical
- Relative Strength Index (RSI)
- OMI 41.61
- ORIC 37.50
- Support Level
- OMI $11.98
- ORIC $10.06
- Resistance Level
- OMI $13.56
- ORIC $11.11
- Average True Range (ATR)
- OMI 0.71
- ORIC 0.81
- MACD
- OMI -0.01
- ORIC -0.05
- Stochastic Oscillator
- OMI 35.78
- ORIC 13.00
About OMI Owens & Minor Inc.
Owens & Minor Inc distributes consumable medical supplies to a variety of providers. The business is under two segments: Products & Healthcare Services and Patient Direct. The Products & Healthcare Services segment manufactures and sources medical surgical products through its production and kitting operations and provides medical supplies and solutions for the prevention of healthcare-associated infections across the acute and alternate site channels. The Patient Direct segment provides delivery of disposable medical supplies sold directly to patients and home health agencies. Majority of the revenue is generated from Products & Healthcare Services segment.
About ORIC Oric Pharmaceuticals Inc.
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533.